| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.094 | 0.09 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.091 | 0.1 |